可穿戴注射器市场趋势、份额和全球规模 - 2027 年

  • Report Code : TIPMD00002677
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 184
Buy Now

[研究报告]可穿戴式注射器市场规模预计将从2019年的57.9123亿美元增至2027年的138.8088亿美元。预计2020年至2027年复合年增长率为11.6% .

市场洞察和分析师观点:

可穿戴注射系统是药物输送装置粘附在身体上并在最佳时间自动向患者输送设定剂量。预充式注射器和自动注射器可在 20 秒内将药物输送给患者。然而,胰岛素泵对于定期固定容量的药物输送而言昂贵且复杂。可穿戴注射系统旨在填补这两个空白,能够在固定或可变的时间内舒适、低调地输送精确剂量的药物。随着可穿戴注射系统的出现来应对这些条件,设备设计和测试方面也面临着一系列新的挑战。慢性病患病率的上升和新产品的推出推动了可穿戴注射器市场的增长。随着糖尿病的日益普及,人们对该疾病的认识不断增强,以及使用可穿戴注射器进行相关治疗也推动了可穿戴注射器市场的增长。

此外,政府举措还提供了更好、更实惠的治疗方法和优惠的报销政策预计将推动可穿戴注射器市场的增长。此外,可穿戴注射器市场的主要参与者正在专注于战略举措,通过推出新产品来扩大其地理覆盖范围并增强迎合庞大客户群的能力。例如,2020年1月,Tandem Diabetes Care, Inc.在美国市场推出了采用Control-IQ技术的t:slim X2胰岛素泵。 t:slim X2 胰岛素泵设备采用 Control-IQ 技术运行。它使用 CGM 值和其他变量(例如船上胰岛素)提前 30 分钟预测传感器血糖水平,并相应地调节胰岛素输送。

战略见解

市场范围和细分:

“全球可穿戴注射器市场”是一项专注于市场趋势和增长机会的专业和深入的研究。该报告旨在概述可穿戴注射器市场,并按类型、应用、最终用户和地理位置进行详细的市场细分。根据该报告的范围,可穿戴注射器市场按产品分为穿戴式注射器和离体式注射器。根据应用,市场分为肿瘤学、糖尿病、自身免疫性疾病、心血管疾病和其他应用。可穿戴注射器市场根据最终用户分为家庭护理场所、医院和诊所以及其他场所。根据地理位置,可穿戴注射器市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国) ,以及亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

该报告评估了预测期内的市场动态,即驱动因素、限制因素、机会和全球可穿戴市场注射器市场的未来趋势。该报告还提供了所有五个地区的详尽 PEST 分析:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲。中美洲,在评估影响这些地区市场的政治、经济、社会和技术因素后。

市场驱动因素:

可穿戴式注射器市场根据类型分为穿戴式注射器和离体式注射器。 2019 年,贴身注射器细分市场占据了最大的可穿戴注射器市场份额。贴身注射器具有舒适性、防水性、灵活剂量和冷藏药物自动加温等优点,并且易于使用。这些优点增加了对身上注射器的需求。相比之下,离体注射器细分市场在预测期内以 12.3% 的复合年增长率快速增长。

根据应用,可穿戴注射器市场分为肿瘤学、糖尿病、自身免疫性疾病、心血管疾病和其他应用。 2019 年,肿瘤学领域占据了最大的可穿戴注射器市场份额。然而,预计在预测期内,自身免疫性疾病领域的可穿戴注射器市场的复合年增长率最高。癌症包括由恶性细胞生长失控引起的各种疾病。癌症是死亡率很高的重大健康问题之一。由于其优点,例如减少癌症患者的疾病进展和疼痛,可穿戴式注射器在医疗保健行业的采用率大幅增加。体上注射器放置在胃部或手臂背部。医疗保健专业人员在化疗周期的最后一天使用它。因此,癌症患病率的上升是该细分市场增长的主要驱动力之一。根据最终用户,市场分为家庭护理环境、医院和诊所等。家庭护理设置细分市场在 2019 年以最高的市场份额引领市场,预计在预测期内将保持最高份额。由于自我用药的倾向不断增强以及降低医疗保健成本的需求不断增加,预计家庭护理领域将占据主导地位。该医院通过为患有各种疾病的患者提供广泛的医疗服务而发挥着重要作用。这增加了医院和诊所对药物输送系统的采用。这以及不断增长的住院人数将推动该细分市场的增长。预测期内医院和诊所的增长率预计为 12.2%。全球可穿戴注射器的其他最终用户是门诊手术中心、疗养院、诊断中心和其他使用药物输送设备的医疗中心。

区域分析:< /strong>

该报告详细概述了全球可穿戴注射器市场,包括定性和定量信息。它提供了 2019 年至 2027 年全球可穿戴注射器市场的概述和预测,涉及五个主要地区:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和非洲。中美洲。每个地区的可穿戴注射器市场随后按各自的国家和细分市场进行细分。该报告涵盖了全球18个国家的分析和预测以及该地区当前的趋势和机遇。

北美是可穿戴注射器市场的主导地区。北美可穿戴注射器市场预计在预测期内复合年增长率为 11.9%。根据美国、加拿大和墨西哥地区分析了北美可穿戴注射器市场。癌症、糖尿病、肿瘤、心血管疾病等慢性疾病患病率的上升是北美市场增长的特征。随着创新产品的开发和该地区主要市场参与者的出现。此外,美国糖尿病患病率的不断上升可能会推动该国可穿戴注射器市场的增长。 2021年,美国疾病控制与预防中心(CDC)发布的《国家糖尿病统计报告》称,美国有近3730万人患有糖尿病,其中1型糖尿病患者约145万。癌症患病率的不断上升预计将增加北美对可穿戴注射器的需求。例如,根据美国癌症协会的数据,2022 年将发现约 190 万新癌症病例。乳腺癌、前列腺癌和黑色素瘤是该国常见的癌症类型。此外,治疗疾病的技术进步可能成为北美可穿戴注射器市场的主要增长刺激因素。例如,2018年6月,美国触摸屏胰岛素泵制造商Tandem Diabetes Care, Inc.的t:slim X2胰岛素泵获得美国食品和药物管理局(FDA)批准。该泵采用 Basal-IQ 技术,具有预测性低血糖暂停 (PLGS) 功能,有助于减少低血糖事件(低血糖)的频率和持续时间。

亚太地区是所有地区中增长最快的可穿戴注射器市场。预计亚太地区的复合年增长率为 12.4%。中国、印度和日本是市场增长的三个主要贡献者。这些国家通过老年人口的增加、慢性病患病率的增加以及可穿戴医疗设备领域的研究来推动增长。此外,政府的支持性举措和国际市场参与者的投资推动了市场的增长。

主要参与者分析:

该报告涵盖了全球可穿戴注射器市场的主要发展,包括有机和无机增长战略。全球可穿戴注射器市场参与者预计将拥有利润丰厚的增长机会。可穿戴注射器市场分析的参与者包括 Amgen, Inc.、Medtronic、BD、Insulet Corporation、Gerresheimer AG (Sensile Medical)、West Pharmaceutical Services, Inc.、Ypsomed AG、Tandem Diabetes Care, Inc.、CeQur SA、 Debiotech SA、Zealand Pharma A/S、Elcam Medical。由于产品组合多元化,安进公司和美敦力是可穿戴注射器市场的两大巨头。

最新进展:

可穿戴注射器市场的公司高度采用并购等无机和有机策略。下面列出了最近的一些关键市场动态:

  1. 2022 年 11 月,美敦力 (Medtronic) 推出了美敦力 (Medtronic) 延长输液器,这是第一个也是唯一一个标有长达 7 天的输液器穿。由于减少了输液器和储液器的更换次数以及塑料废物减少高达 50%,预计这项创新可节省高达 25% 的胰岛素。
  2. 2020 年 12 月,BD Libertas 可穿戴注射器已通过 52 名受试者的人体临床试验。该注射器是一种皮下给药系统,无需患者组装即可以 2-5 mL 和 5-10 mL 配置输送粘度高达 50 cP 的生物制剂。
  3. 2020 年 4 月,西兰Pharma A/S 以约 2,300 万美元现金收购了 Valeritas Holdings, Inc. 的全部资产。此次收购有助于扩展其现有制药业务的业务。
  4. 2020 年 1 月,Tandem Diabetes Care 在美国推出了采用 Control-IQ 技术的 t:slim X2 胰岛素泵
  5. 2019 年 9 月,Insulet Corporation 的备用控制器输液泵获得美国 FDA 批准。此次批准使该公司能够将其 Omni pod DASH 胰岛素管理系统作为集成胰岛素泵进行销售。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the wearable injectors?

Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. Wearable injectors consist of a reservoir for the medication, a cannula for delivery to the tissue, adhesive to fix the device to the patient’s skin, and a drive system to deliver the appropriate drug volume.

What are the driving factors for the wearable injectors market across the globe?

The global wearable injectors market is being driven by factors such as the increasing chronic diseases prevalence, technological advancements & design development, and conventional drug delivery system limitations. Furthermore, increasing demand for biologics is likely to offer significant opportunities for the growth of the global wearable injectors market.

What are the restraining factors for the wearable injectors market across the globe?

The lack of adoption in emerging countries is the significant factor that will impede the wearable injectors market growth. The development of biopharmaceuticals and complex chemicals, along with novel approaches to drug delivery, is driven owing to a vast portion of the population suffering from chronic conditions across the world. In developed countries, insurance coverage helps in the adoption of innovative technologies, such as wearable injector devices, whereas, in developing countries, a large portion of the population is not able to afford necessary treatment drugs for chronic diseases.

The List of Companies - Wearable Injectors Market

  1. Amgen, Inc.
  2. Medtronic
  3. BD
  4. Insulet Corporation
  5. Gerresheimer AG (Sensile Medical)
  6. West Pharmaceutical Services, Inc.
  7. Ypsomed AG,
  8. Tandem Diabetes Care, Inc.
  9. Cequr SA
  10. Debiotech S.A
  11. E3D Elcam Drug Delivery Devices
  12. Zealand Pharma A/S (Valeritas, Inc.)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports